RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study
RECIST 和 iRECIST 标准用于评估纳武利尤单抗联合伊匹木单抗治疗微卫星不稳定性高/错配修复缺陷型转移性结直肠癌患者的疗效:GERCOR NIPICOL II 期研究
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2020-001499
Cohen, Romain; Bennouna, Jaafar; Meurisse, Aurélia; Tournigand, Christophe; De La Fouchardière, Christelle; Tougeron, David; Borg, Christophe; Mazard, Thibault; Chibaudel, Benoist; Garcia-Larnicol, Marie-Line; Svrcek, Magali; Vernerey, Dewi; Menu, Yves; André, Thierry